Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Tumor Microenvironment and the Estrogen Loop in Thyroid Cancer.
Denaro N, Romanò R, Alfieri S, Dolci A, Licitra L, Nuzzolese I, Ghidini M, Bareggi C, Bertaglia V, Solinas C, Garrone O. Denaro N, et al. Cancers (Basel). 2023 Apr 25;15(9):2458. doi: 10.3390/cancers15092458. Cancers (Basel). 2023. PMID: 37173925 Free PMC article. Review.
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus.
Russi EG, Moretto F, Rampino M, Benasso M, Bacigalupo A, De Sanctis V, Numico G, Bossi P, Buglione M, Lombardo A, Airoldi M, Merlano MC, Licitra L, Denaro N, Pergolizzi S, Pinto C, Bensadoun RJ, Girolomoni G, Langendijk JA. Russi EG, et al. Among authors: denaro n. Crit Rev Oncol Hematol. 2015 Oct;96(1):167-82. doi: 10.1016/j.critrevonc.2015.06.001. Epub 2015 Jul 2. Crit Rev Oncol Hematol. 2015. PMID: 26187236 Review.
Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide.
Merlano MC, Merlotti AM, Licitra L, Denaro N, Fea E, Galizia D, Di Maio M, Fruttero C, Curcio P, Vecchio S, Russi EG, Corvò R. Merlano MC, et al. Among authors: denaro n. Clin Transl Radiat Oncol. 2018 Aug 13;12:47-52. doi: 10.1016/j.ctro.2018.08.001. eCollection 2018 Aug. Clin Transl Radiat Oncol. 2018. PMID: 30186977 Free PMC article.
Knowing the tumour microenvironment to optimise immunotherapy.
Merlano MC, Abbona A, Denaro N, Garrone O. Merlano MC, et al. Among authors: denaro n. Acta Otorhinolaryngol Ital. 2019 Feb;39(1):2-8. doi: 10.14639/0392-100X-2481. Acta Otorhinolaryngol Ital. 2019. PMID: 30936573 Free PMC article. Review.
How I treat squamous ENT cancer.
Merlano MC, Denaro N, Galizia D, Garrone O. Merlano MC, et al. Among authors: denaro n. ESMO Open. 2019 Jul 16;4(Suppl 2):e000542. doi: 10.1136/esmoopen-2019-000542. eCollection 2019. ESMO Open. 2019. PMID: 31555490 Free PMC article. Review.
Phase III Randomized Study of Induction Chemotherapy Followed by Definitive Radiotherapy + Cetuximab Versus Chemoradiotherapy in Squamous Cell Carcinoma of Head and Neck: The INTERCEPTOR-GONO Study (NCT00999700).
Merlano MC, Denaro N, Vecchio S, Licitra L, Curcio P, Benasso M, Bagicalupo A, Numico G, Russi E, Corvo' R, Bruzzi P; INTERCEPTOR trialists. Merlano MC, et al. Among authors: denaro n. Oncology. 2020;98(11):763-770. doi: 10.1159/000507733. Epub 2020 Jul 6. Oncology. 2020. PMID: 32629446 Free article. Clinical Trial.
84 results